Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-13 LEWIS JOEL President and CEO Grant or award +9,585 $2.01 $19K 989,025
2023-10-13 LEWIS JOEL President and CEO Grant or award +10,035 $2.01 $20K 989,025
2023-09-29 LEWIS JOEL President and CEO Grant or award +10,035 $1.92 $19K 979,440
2023-09-26 Uihlein Richard E Director Exercise or conversion +1,466,204 $5.00 $7.3M 9,466,495
2023-09-26 Uihlein Richard E Director Exercise or conversion +170,000 $5.00 $850K 9,635,495
2023-09-26 Uihlein Richard E Director Exercise or conversion +200,000 $3.00 $600K 9,835,495
2023-09-26 Uihlein Richard E Director Exercise or conversion +200,000 $3.26 $652K 10,035,495
2023-09-26 Uihlein Richard E Director Exercise or conversion +200,000 $3.00 $600K 10,235,495
2023-09-26 Uihlein Richard E Director Exercise or conversion · Common Stock Purchase Warrant (right to buy) −1,466,204 0
2023-09-26 Uihlein Richard E Director Exercise or conversion · Common Stock Purchase Warrant (right to buy) −170,000 330,000
2023-09-26 Uihlein Richard E Director Exercise or conversion · Common Stock Purchase Warrant (right to buy) −200,000 0
2023-09-26 Uihlein Richard E Director Exercise or conversion · Common Stock Purchase Warrant (right to buy) −200,000 0
2023-09-26 Uihlein Richard E Director Exercise or conversion · Common Stock Purchase Warrant (right to buy) −200,000 0
2023-09-15 LEWIS JOEL President and CEO Grant or award +10,947 $1.76 $19K 969,405
2023-08-31 LEWIS JOEL President and CEO Grant or award +11,010 $1.75 $19K 958,458
2023-08-15 LEWIS JOEL President and CEO Grant or award +12,042 $1.60 $19K 947,448
2023-07-31 LEWIS JOEL President and CEO Grant or award +12,844 $1.50 $19K 935,406
2023-07-19 ELDRED KARY Director Purchase +1,598 $1.79 $3K 48,813
2023-07-14 LEWIS JOEL President and CEO Grant or award +11,820 $1.63 $19K 922,562
2023-06-30 LEWIS JOEL President and CEO Grant or award +13,380 $1.44 $19K 910.74

Page 16 of 21 · 404 trades